Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

A stochastic model for optimizing composite predictors based on gene expression profiles.

Murali Ramanathan1

  • 1Department of Pharmaceutical Sciences, State University of New York at Buffalo, Buffalo, New York 14260-1200, USA. murali@acsu.buffalo.edu

Pharmaceutical Research
|July 26, 2003
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

First step towards predicting clinical immunogenicity of biologics using in vitro based readouts as animal trial alternatives.

Journal of pharmaceutical sciences·2026
Same author

Retrieval Augmented Generation (RAG) for Evaluating Regulatory Compliance of Drug Information and Clinical Trial Protocols.

CPT: pharmacometrics & systems pharmacology·2026
Same author

Oxylipin Biomarkers of Auto-Oxidation Are Associated with Antioxidant Micronutrients and Multiple Sclerosis Disability.

Antioxidants (Basel, Switzerland)·2026
Same author

Retrieval Augmented Generation (RAG) for Natural Language Querying of Immunogenicity Data for Protein Drugs.

The AAPS journal·2026
Same author

Frailty Exacerbates Disability in Progressive Multiple Sclerosis.

Annals of clinical and translational neurology·2025
Same author

Network Modeling of Biomarker Systems in Liver Steatosis and Fibrosis.

Clinical and translational science·2025
Same journal

Leveraging Carnitine-functionalized Lipid Nanocarrier based Targeted Delivery of A1874 PROTAC for Glioblastoma.

Pharmaceutical research·2026
Same journal

Impact of Febrile State on Vancomycin Clearance in Pediatric Patients: Insights From Population Pharmacokinetic Modeling.

Pharmaceutical research·2026
Same journal

Sustained Intra-Articular Delivery of Triple Therapeutics Using a Phase-Transition Phospholipid-Based Gel for Effective Treatment of Gouty Arthritis.

Pharmaceutical research·2026
Same journal

Spray Dried Lysozyme Microspheres: Morphological Evolution and Enzymatic Activity Retention.

Pharmaceutical research·2026
Same journal

Colloidal Stability of Amorphous Nanoparticles in Solution: Impact of Stabilizer.

Pharmaceutical research·2026
Same journal

Impact of Mixing Approach and Bubble Formation on In Situ Forming Implant Properties.

Pharmaceutical research·2026
See all related articles

This study developed a mathematical model for optimizing composite biomarkers using gene expression data. The model, analogous to portfolio optimization, efficiently combines gene data for improved treatment effect prediction.

Area of Science:

  • Bioinformatics
  • Computational Biology
  • Mathematical Finance

Background:

  • Gene expression profiling and proteomics are crucial for understanding disease mechanisms and treatment responses.
  • Developing accurate composite predictors from high-dimensional biological data presents a significant challenge.

Purpose of the Study:

  • To develop a mathematical model for optimizing composite predictors using gene expression profiles.
  • To apply principles from portfolio optimization to biological data analysis.

Main Methods:

  • Formulated the optimization problem analogous to the Markowitz portfolio optimization model.
  • Utilized a quadratic function with linear constraints for optimization.
  • Compared the model's performance against neighborhood analysis using patient gene expression data.

Related Experiment Videos

Main Results:

  • The Markowitz model demonstrated that gene covariance can be leveraged to create efficient composites.
  • Optimized composites yield the highest mean treatment effect for a given variability or the least variability for a given mean.
  • The developed model-based composite outperformed the composite derived from neighborhood analysis.

Conclusions:

  • The Markowitz portfolio model offers a novel approach for constructing composite biomarkers.
  • Potential applications include pharmacogenomic modeling of treatment effects from gene expression data.